L

LivaNova PLC

D
LIVN
USD
-0.13
(-0.2495%)
Market Closed
11,589.00
Volume
1.95
EPS
-
Div Yield
-167.677410
P/E
2,822,407,960.80
Market Cap
Today
-0.2495%
1 Week
0.736%
1 Month
-1.310%
6 Months
-17.649%
12 Months
9.478%
Year To Date
0.464%
All Time
0%
News

BYD Sets New Sales Record Amidst China’s EV Market Slowdown

02.09.2024
Stocks news

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news

Xiaomi's Stock Surges After it Releases its First EV

02.04.2024
Stocks news
More
Related Instruments
ISRG
ISRG
9.03
(1.752%)
USD
BDX
BDX
-13.09
(-5.4521%)
USD
MDT
MDT
-1.99
(-2.2084%)
USD
TMO
TMO
-4.75
(-0.847%)
USD
ABT
ABT
-2.38
(-2.0223%)
USD
SYK
SYK
-3.16
(-0.8471%)
USD
EW
EW
-0.86
(-1.2894%)
USD
C
COO
-0.34
(-0.3277%)
USD
BSX
BSX
0.45
(0.5205%)
USD
Z
ZBH
-1.51
(-1.3702%)
USD

Title:
LivaNova PLC

Sector:
Healthcare
Industry:
Medical Devices
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.
Do you need help or have a question?
Contact Us